AMPICILLIN AND SULBACTAM by Novartis is mechanism of action ampicillin is similar to benzyl penicillin in its bactericidal action against susceptible organisms during the stage of active multiplication. Approved for infections due to susceptible strains of the designated microorganisms in the conditions listed below. First approved in 2006.
Drug data last refreshed 17h ago
Mechanism of Action Ampicillin is similar to benzyl penicillin in its bactericidal action against susceptible organisms during the stage of active multiplication. It acts through the inhibition of cell wall mucopeptide biosynthesis. Ampicillin has a broad spectrum of bactericidal activity against…
Worked on AMPICILLIN AND SULBACTAM at Novartis? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.